Liver Diseases
331
39
48
153
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
33 trials with published results (10%)
Research Maturity
153 completed trials (46% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.0%
20 terminated out of 331 trials
88.4%
+1.9% vs benchmark
8%
28 trials in Phase 3/4
22%
33 of 153 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 153 completed trials
Clinical Trials (331)
Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting Time
A Study About Remote and Local Liver Surgery
Genomic Medicine Risk Assessment Care for Everyone - Implementation Phase
DILIN - Prospective Study
Mindfulness and Shared Decision Making
GATT-Patch Versus TachoSil in Liver Surgery
Research on Construction and Verification of Multimodal Medical Imaging Large Model
Liver Cancer Prevention Randomized Control Trial
Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients
GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery
A Study Evaluating How Moderate Liver Impairment Affects the Absorption, Distribution, Metabolism, and Elimination of Sevabertinib After a Single Oral Dose
Development of a FibroScan Liver Examination Using a Single Probe
Veteran-Centered Care for Advanced Liver Disease (Vet-CALD)
Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
RTX001 Autologous Engineered Macrophages for Liver Cirrhosis
Social & Contextual Impact on Children Undergoing Liver Transplantation
Breath Analysis Based Disease Biomarkers
MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease
Prediction of Decompensation and HCC Development in Advanced Chronic Liver Disease
Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver Transplantation